Medical Marijuana Inc (OTCMKTS:MJNA)
Cannabidiol (“CBD”) is increasingly gaining recognition as the best cannabinoid compound with potential to treat several hard-to-treat ailments. Research has proved the compound’s ability to treat refractory epilepsy (“RE”) and even get rid of it altogether. Refractory epilepsy is hard to treat using traditional anti-epileptic treatments.
RSHO-X™, produced by Medical Marijuana Inc (OTCMKTS:MJNA), is being tested in several studies to establish the medical benefits and effectiveness of RSHO-X™. The company previously released an update on a study carried out by Dr. Saul Garza Morales, a Mexican pediatric neurologist, that showed the RSHO-X™’s effects in treating severe epilepsy in young children. The study, which examined 39 patients, established that those administered with 5-7mg of CBD/kg reported 84% decrease in motor seizures with seven of the patients reported full elimination of all forms of seizure during the four months without any serious side effect.
The Por Grace Foundation out of Mexico issued an update on April 5th concerning a new study of parents with children suffering from refractory epilepsy. Out of the 43 families involved in the study, over 80% of the children reported a decrease in convulsions as a result of use of CBD oil and over 70% of the children were treated with RSHO-X™. Currently, RSHO-X™ is the only authorized medical option for parents looking to buy CBD oil that is approved by COFEPRIS. Most importantly, over 20% of the patients reduced the amount of anti-epileptic pharmaceuticals they were taking as a result of cannabidiol’s positive results.
Epilepsy is a chronic and common neurological disorder affecting over 50 million people globally. Mexico has 1.5 million epilepsy patients with 80% of these receiving minimal treatment and while 30% of the patients have refractory epilepsy which does not respond to convectional anti-epileptic medication. RSHO-X™ is meant to solve the problem that many patients are facing with an affordable and effective alternative.
Medical Marijuana Inc (OTCMKTS:MJNA) has built a strong grassroots presence for the RSHO-X™, as well as for related products, in Argentina, Paraguay, Brazil, Mexico and other countries. The company starts by acquiring rights into the respective countries which boosts its brand value against that of unlicensed competitors. The company then validates its products by working with researchers and physicians so as to showcase its effectiveness in treating several conditions. Medical Marijuana Inc (OTCMKTS:MJNA) raises awareness about the product, markets and commercializes it in the respective countries.
I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.
About the author: Monica Gray has an undergraduate degree in Accounting and an MBA – earned with Honors. She has six years of experience in the financial markets and has been a securities analyst for the past two years.